Oman’s Salalah Free Zone (SFZ) and Flex Pharmaceuticals, a biotechnology company, have recently signed an agreement to set up an international complex for pharmaceutical industries at a cost of $365 million, said a report. The complex will produce more than 100 compound drugs, reported the Times of Oman. Jassim Al Misnad, chairman of Flex ...
Quriyat Development Company (QDC), a joint venture between Omani groups Al Madina Real ...
Nasser Bin Khaled (NBK) Automobiles, the authorised general distributor of Mercedes-Benz ...
Work launched on Bahrain medical city
The Arabian Gulf University has awarded the first of the contracts for the construction of ...
PDO invites developers for 100 MW solar plant
Petroleum Development Oman (PDO) has invited expressions of interest (EoIs) from companies ...
